2,490 Shares in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Purchased by Runnymede Capital Advisors Inc.

Runnymede Capital Advisors Inc. acquired a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 2,490 shares of the company’s stock, valued at approximately $164,000.

Several other large investors also recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new stake in iShares U.S. Pharmaceuticals ETF in the 4th quarter worth about $4,472,000. Pallas Capital Advisors LLC purchased a new position in iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at about $3,829,000. Commonwealth Equity Services LLC grew its holdings in iShares U.S. Pharmaceuticals ETF by 5.5% during the 4th quarter. Commonwealth Equity Services LLC now owns 40,248 shares of the company’s stock valued at $2,645,000 after buying an additional 2,106 shares in the last quarter. Thrivent Financial for Lutherans grew its holdings in iShares U.S. Pharmaceuticals ETF by 4.3% during the 4th quarter. Thrivent Financial for Lutherans now owns 33,916 shares of the company’s stock valued at $2,229,000 after buying an additional 1,407 shares in the last quarter. Finally, Jones Financial Companies Lllp grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 74.6% during the fourth quarter. Jones Financial Companies Lllp now owns 30,913 shares of the company’s stock worth $2,032,000 after purchasing an additional 13,209 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Down 0.3 %

Shares of NYSEARCA IHE opened at $70.21 on Friday. iShares U.S. Pharmaceuticals ETF has a 12 month low of $62.68 and a 12 month high of $73.28. The firm has a market capitalization of $610.83 million, a price-to-earnings ratio of 26.27 and a beta of 0.63. The business has a 50-day moving average of $69.88 and a 200-day moving average of $69.35.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.